Clinical trial
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related…
NCT00003057 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003057 |
|---|---|
| Title | Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer |
| Official title | Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Diarrhea |
| Intervention type | Drug |
| Interventions | loperamide hydrochloride, octreotide acetate |
| Enrollment | 500 |
| Start date | Mar 26, 1997 |
| Primary completion | May 1, 2000 |
| First posted | Jul 19, 2004 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: